Abstract
This study revealed that the content of protein S29 in ribosomes of cancer cell line A549 was distinctly low (equivalent to about 30% of that of 2BS). The conclusion was acquired based on the ratios of spot volume of ribosomal protein S29 to that of several other ribosomal proteins (S29 / L37a, S29 / L38, S29 / S27 and S29 / S28) in the same gel plate. The possible biological roles of ribosomal protein S29 in malignant transformation and translation regulation are briefly discussed.
Keywords: human liver cancer cell line 7721, human lung cancer cell line a549, human lung normal cell line 2bs, human lung cancer, northern blot, ribosomal protein s29, 2-dimensional polyacrylamide gel electrophoresis, cbb-chromium modified thiosulfate-silver staining
Protein & Peptide Letters
Title: Low Content of Protein S29 in Ribosomes of Human Lung Cancer Cell Line A549: Detected by Twodimensional Electrophoresis
Volume: 10 Issue: 1
Author(s): Zhi-Dong Zhou, Lei Bao, Ding-Gan Liu, Min-Qian Li, Yin-Zi Ge, Ying-Ling Huang and Wang-Yi Liu
Affiliation:
Keywords: human liver cancer cell line 7721, human lung cancer cell line a549, human lung normal cell line 2bs, human lung cancer, northern blot, ribosomal protein s29, 2-dimensional polyacrylamide gel electrophoresis, cbb-chromium modified thiosulfate-silver staining
Abstract: This study revealed that the content of protein S29 in ribosomes of cancer cell line A549 was distinctly low (equivalent to about 30% of that of 2BS). The conclusion was acquired based on the ratios of spot volume of ribosomal protein S29 to that of several other ribosomal proteins (S29 / L37a, S29 / L38, S29 / S27 and S29 / S28) in the same gel plate. The possible biological roles of ribosomal protein S29 in malignant transformation and translation regulation are briefly discussed.
Export Options
About this article
Cite this article as:
Zhou Zhi-Dong, Bao Lei, Liu Ding-Gan, Li Min-Qian, Ge Yin-Zi, Huang Ying-Ling and Liu Wang-Yi, Low Content of Protein S29 in Ribosomes of Human Lung Cancer Cell Line A549: Detected by Twodimensional Electrophoresis, Protein & Peptide Letters 2003; 10 (1) . https://dx.doi.org/10.2174/0929866033408273
DOI https://dx.doi.org/10.2174/0929866033408273 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects and Role of Multikinase Inhibitors in Thyroid Cancer
Current Pharmaceutical Design The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
CNS & Neurological Disorders - Drug Targets Targeting the Tumor Stroma in Cancer Therapy
Current Pharmaceutical Biotechnology Stem Cell Transplantation and MBL Replacement Therapy
Current Stem Cell Research & Therapy Novel Insight into Differential Gene Expression and Clinical Significance of Dopamine Receptors, COMT, and IL6 in BPH and Prostate Cancer
Current Molecular Medicine Regulators of Chemokine Receptor Activity as Promising Anticancer Therapeutics
Current Cancer Drug Targets Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy
Current Cancer Drug Targets Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization
Current Topics in Medicinal Chemistry Withdrawal Notice: Therapeutic Effect of Prdx1 on NAFLD Mice May be Related to the Activation of Nrf-2/HO-1 Pathway
Current Pharmaceutical Design JAK3 Inhibitors in Organ Transplantation and Autoimmune Disease
Recent Patents on Inflammation & Allergy Drug Discovery ABC Transporters in the CNS – An Inventory
Current Pharmaceutical Biotechnology Cilostazol as a Unique Antithrombotic Agent
Current Pharmaceutical Design Network Pharmacology: Reigning in Drug Attrition?
Current Drug Discovery Technologies Plant Ribonucleases and Nucleases as Antiproliferative Agens Targeting Human Tumors Growing in Mice
Recent Patents on DNA & Gene Sequences Edelfosine in Membrane Environment - the Langmuir Monolayer Studies
Anti-Cancer Agents in Medicinal Chemistry Cellular Signaling Crosstalk Between Multiple Receptors for Investigation of Pathophysiology in Multifactorial Diseases - What is Clinically-Relevant Crosstalk?
Current Medicinal Chemistry Targeting Heat Shock Proteins 70/90 and Proteasome for Cancer Therapy
Current Medicinal Chemistry Nifurtimox Hampered the Progression of Astroglioma <i>In vivo Via</i> Manipulating the AKT-GSK3β axis
Current Molecular Medicine Epigenetic Regulation of EMT: The Snail Story
Current Pharmaceutical Design